Could Hercules Offshore, Inc. (HERO), Medivation (MDVN), and Bayer AG (ADR) (BAYRY) Be Savvy Investment Options?

Posted by Saimoon December 16, 2014 0 Comment 1195 views


New York, NY – GDP INSIDER  –  12/16/2014.

This day trading article provides an investment analysis of Hercules Offshore, Inc.(NASDAQ:HERO), Medivation(NASDAQ:MDVN), and Bayer AG (ADR)(OTCMKTS:BAYRY)

Hercules Offshore, Inc.(NASDAQ:HERO) presented at the Wells Fargo 2014 Energy Symposium in New York City on Dec. 10th, 2014. A replay of the company’s presentation is available at its website. The stock traded for a new 52 week low of $0.99 yesterday before finishing yesterday’s trading at a closing price of $1.00 after an 8.64% loss of ten cents. These figures indicate that Hercules Offshore Inc. is on the decline. Additionally, the company’s earnings per share (TTM) of $–1.02 is also a warning sign for investors to consider.

Will Hercules Offshore Bounce Back? View Our Free HERO Analysis And Make A Smart Investment Decision.

Medivation(NASDAQ:MDVN) presented its Stage 1 and preliminary Stage 2 data from its Phase 2 evaluation of the use enzalutamide in the treatment of advanced androgen receptor positive, triple negative breast cancer at the 37th Annual San Antonio Breast Cancer Symposium. The stock has a beta of 0.73, which indicates that the stock is 37% less volatile than the market. Additionally, Medivation Inc. also has an earnings per share (TTM) of $1.44, a price to earnings ratio (TTM) of $72.13, and a market capitalization of $8.08 billion.

Should You Invest In Medivation? Receive A Free MDVN Analysis And Learn More About The Company’s Trajectory.

Bayer AG (ADR)(OTCMKTS:BAYRY) recently announced that it had submitted a Marketing Authorization Application in Europe for its BAY 81-8973 product, which would be used to treat children and adults who are suffering from hemophilia A. The company had a trading volume of 0.08 million yesterday, which is 0.03 million greater than its three month average volume of 0.05 million. Simpl put, investor interest in Bayer AG is on the rise. The company has a one-year target estimate of $165, which is $29 greater than its most recent closing price

Can Bayer Maintain Its Value? Get A Jump On Wall Street With Our Free BAYRY Analysis.

About HotStockGains

HotStockGains.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.

Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.


Write Your Comment